1,3-dicyclohexylurea has been researched along with 14,15-dihydroxyeicosatrienoic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Falck, JR; Fang, X; Harmon, S; Hu, S; Liu, Y; Sangras, B; Snyder, GD; Spector, AA; Weintraub, NL; Xu, B; Yao, J | 1 |
| Chiang, PC; Fujiwara, H; Ghosh, S; Roberds, SL; Selbo, JG; Wahlstrom, JL | 1 |
2 other study(ies) available for 1,3-dicyclohexylurea and 14,15-dihydroxyeicosatrienoic acid
| Article | Year |
|---|---|
14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arachidonic Acids; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Epoxide Hydrolases; Epoxy Compounds; Humans; PPAR alpha; Urea | 2006 |
Oral delivery of 1,3-dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive rats.
Topics: 8,11,14-Eicosatrienoic Acid; Administration, Oral; Animals; Blood Pressure; Chromatography, Liquid; Disease Models, Animal; Epoxide Hydrolases; Hypertension; Male; Nanoparticles; Particle Size; Rats; Rats, Sprague-Dawley; Solubility; Suspensions; Tandem Mass Spectrometry; Urea | 2008 |